Deregulation of allosteric inhibition of enzymes is a challenge for strain engineering and has been achieved so far primarily by random mutation and trial-and-error. In this work, we used aspartokinase, an important allosteric enzyme for industrial amino acids production, to demonstrate a predictive approach that combines protein dynamics and evolution for a rational reengineering of enzyme allostery. Molecular dynamic simulation of aspartokinase III (AK3) from Escherichia coli and statistical coupling analysis of protein sequences of the aspartokinase family allowed to identify a cluster of residues which are correlated during protein motion and coupled during the evolution. This cluster of residues forms an interconnected network mediating the allosteric regulation, including most of the previously reported positions mutated in feedback insensitive AK3 mutants. Beyond these mutation positions, we have successfully constructed another twelve targeted mutations of AK3 desensitized toward lysine inhibition. Six threonine-insensitive mutants of aspartokinase I-homoserine dehydrogenase I (AK1-HD1) were also created based on the predictions. The proposed approach can be widely applied for the deregulation of other allosteric enzymes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbiotec.2011.05.005DOI Listing

Publication Analysis

Top Keywords

deregulation allosteric
12
allosteric inhibition
8
cluster residues
8
allosteric
5
aspartokinase
5
integrating molecular
4
molecular dynamics
4
dynamics co-evolutionary
4
co-evolutionary analysis
4
analysis reliable
4

Similar Publications

Peptidylarginine deiminase IV (PADI4, PAD4) deregulation promotes the development of autoimmunity, cancer, atherosclerosis and age-related tissue fibrosis. PADI4 additionally mediates immune responses and cellular reprogramming, although the full extent of its physiological roles is unexplored. Despite detailed molecular knowledge of PADI4 activation in vitro, we lack understanding of its regulation within cells, largely due to a lack of appropriate systems and tools.

View Article and Find Full Text PDF
Article Synopsis
  • Multiple myeloma (MM) is a serious illness where certain blood cells grow uncontrollably in the bone marrow, making it hard for patients to get better.
  • Researchers found that a special type of RNA called NEAT1 helps these cancer cells grow, making it a potential target for new treatments.
  • They discovered that combining NEAT1 blockage with a specific drug called AURKA inhibitors could kill these cancer cells more effectively, especially since high levels of both NEAT1 and AURKA are linked to worse health outcomes in patients.
View Article and Find Full Text PDF

There are two paralogs of glutamate dehydrogenase (GDH) in humans encoded by the and genes as a result of a recent retroposition during the evolution of primates. The two human GDHs possess significantly different regulation by allosteric ligands, which is not fully characterized at the structural level. Recent advances in identification of the GDH ligand binding sites provide a deeper perspective on the significance of the accumulated substitutions within the two GDH paralogs.

View Article and Find Full Text PDF

prediction of mutation sites for anthranilate synthase from to deregulate tryptophan feedback inhibition.

J Biomol Struct Dyn

November 2024

Biodesign Center, Key Laboratory of Engineering Biology for Low-carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.

Allosteric feedback inhibition of the committed step in amino acid biosynthetic pathways is a major concern for production of amino acids at industrial scale. Anthranilate synthase (AS) catalyzes the first reaction of tryptophan biosynthetic pathway found in microorganisms and is feedback inhibited by its own product i.e.

View Article and Find Full Text PDF

Amyotrophic lateral sclerosis (ALS) is a multifactorial neurodegenerative disease characterized by progressive depletion of motor neurons (MNs). Recent evidence suggests a role in ALS pathology for the C-X-C motif chemokine receptor 2 (CXCR2), whose expression was found increased at both mRNA and protein level in cortical neurons of sporadic ALS patients. Previous findings also showed that the receptor inhibition is able to prevent iPSC-derived MNs degeneration in vitro and improve neuromuscular function in SOD1-G93A mice.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!